Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Hernando, V; Alejos, B; Monge, S; Berenguer, J; Anta, L; Vinuesa, D; Palacios, R; Muga, R; Moreno, S; Jarrin, I.

All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010

BMC INFECTIOUS DISEASES. 2013; 13: Nº de citas: 20 [doi:10.1186/1471-2334-13-382]

Ribera, E; Larrousse, M; Curran, A; Negredo, E; Clotet, B; Estrada, V; Sanz, J; Berenguer, J; Rubio, R; Pulido, F; Ferrer, P; Alvarez, ML; Arterburn, S; Martinez, E.

Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study

HIV MEDICINE. 2013; 14(6): 327-336 Nº de citas: 11 [doi:10.1111/hiv.12011]

Demelo-Rodríguez P; González-Munera A; Tejerina F; Bernaldo De Quirós JC.

Síndrome de Fitz-Hugh-Curtis en fase subaguda/crónica.

Revista clínica espanõla. 2013; 213(5): [doi:10.1016/j.rce.2013.01.004]

Pedrol, E; de Quiros, JCLB; Ruiz, S; Hevia, H; Ledesma, F.

Reasons for the introduction of darunavir in the antirretroviral treatment in HIV-infected patients

Revista Espanola de Quimioterapia. 2013; 26(2): 103-107

Berenguer, J; Alvarez-Pellicer, J; Carrero, A; Von Wichmann, MA; Lopez-Aldeguer, J; Mallolas, J; Galindo, MJ; Van den Eynde, E; Tellez, MJ; Quereda, C; Tural, C; Sanz, J; Barros, C; Santos, I; Pulido, F; Guardiola, JM; Ortega, E; Rubio, R; Jusdado, JJ; Montes, ML; Gaspar, G; Barquilla, E; Bellon, JM; Gonzalez-Garcia, J.

Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus

JOURNAL OF HEPATOLOGY. 2013; 58(6): 1104-1112 Nº de citas: 25 [doi:10.1016/j.jhep.2013.01.042]

Guzman-Fulgencio, M; Berenguer, J; Rallon, N; Fernandez-Rodriguez, A; Miralles, P; Soriano, V; Jimenez-Sousa, MA; Cosin, J; Medrano, J; Garcia-Alvarez, M; Lopez, JC; Benito, JM; Resino, S.

HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy

AIDS. 2013; 27(8): 1231-1238 Nº de citas: 18 [doi:10.1097/QAD.0b013e32835f5b9c]

Ribera, JM; Garcia, O; Grande, C; Esteve, J; Oriol, A; Bergua, J; Gonzalez-Campos, J; Vall-Ilovera, F; Tormo, M; Hernandez-Rivas, JM; Garcia, D; Brunet, S; Alonso, N; Barba, P; Miralles, P; Llorente, A; Montesinos, P; Moreno, MJ; Hernandez-Rivas, JA; Bernal, T.

Dose-Intensive Chemotherapy Including Rituximab in Burkitt's Leukemia or Lymphoma Regardless of Human Immunodeficiency Virus Infection Status Final Results of a Phase 2 Study (Burkimab)

CANCER. 2013; 119(9): 1660-1668 Nº de citas: 58 [doi:10.1002/cncr.27918]

Jimenez-Sousa, MA; Berenguer, J; Rallon, N; Guzman-Fulgencio, M; Lopez, JC; Soriano, V; Fernandez-Rodriguez, A; Cosin, J; Restrepo, C; Garcia-Alvarez, M; Miralles, P; Benito, JM; Resino, S.

IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus-/HCV-coinfected patients

JOURNAL OF VIRAL HEPATITIS. 2013; 20(5): 358-366 Nº de citas: 16 [doi:10.1111/jvh.12041]

Teira, R; Suarez-Lozano, I; Lozano, F; Viciana, P; Domingo, P; Galindo, P; Geijo, P; Terron, A; Cosin, J; Ribera, E; Roca, B; Garcia-Alcalde, ML; Sanchez, T; Munoz-Sanz, A; Romero, A; Lopez-Aldeguer, J; Pedrol, E; Vidal, F; Garrido, M; Munoz, P; Puig, T; Deig, E; Estrada, V; Castano, M.

Hepatitis-B virus infection predicts mortality of HIV and hepatitis C virus coinfected patients

AIDS. 2013; 27(5): 845-848 Nº de citas: 11 [doi:10.1097/QAD.0b013e32835ecaf7]

Garcia-Alvarez, M; Berenguer, J; Alvarez, E; Guzman-Fulgencio, M; Cosin, J; Miralles, P; Catalan, P; Lopez, JC; Rodriguez, JM; Micheloud, D; Munoz-Fernandez, MA; Resino, S.

Association of torque teno virus (TTV) and torque teno mini virus (TTMV) with liver disease among patients coinfected with human immunodeficiency virus and hepatitis C virus

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2013; 32(2): 289-297 Nº de citas: 35 [doi:10.1007/s10096-012-1744-1]

Guzman-Fulgencio, M; Berenguer, J; Garcia-Alvarez, M; Fernandez-Rodriguez, A; Jimenez-Sousa, MA; Alvarez, E; Micheloud, D; Lopez, JC; Miralles, P; Cosin, J; Catalan, P; Resino, S.

IL28B polymorphisms are associated with severity of liver disease in human immunodeficiency virus (HIV) patients coinfected with hepatitis C virus

JOURNAL OF INFECTION. 2013; 66(2): 170-178 Nº de citas: 15 [doi:10.1016/j.jinf.2012.10.025]

Fernandez-Rodriguez, A; Rallon, N; Berenguer, J; Jimenez-Sousa, MA; Cosin, J; Guzman-Fulgencio, M; Restrepo, C; Lopez, JC; Garcia-Alvarez, M; Miralles, P; Soriano, V; Benito, JM; Resino, S.

Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV-coinfected patients

AIDS. 2013; 27(2): 163-173 Nº de citas: 10 [doi:10.1097/QAD.0b013e32835c11e8]

Masia, M; Padilla, S; Alvarez, D; Lopez, JC; Santos, I; Soriano, V; Hernandez-Quero, J; Santos, J; Tural, C; del Amo, J; Gutierrez, F.

Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients: role of antiretroviral therapy

AIDS. 2013; 27(2): 181-189 Nº de citas: 51 [doi:10.1097/QAD.0b013e32835a1156]

Garcia-Alvarez, M; Berenguer, J; Guzman-Fulgencio, M; Alvarez, E; Cosin, J; Micheloud, D; Jimenez-Sousa, MA; Fernandez-Rodriguez, A; Aldamiz-Echevarria, T; Carrero, A; Miralles, P; Resino, S.

Bacterial DNA Translocation and Liver Disease Severity Among HIV-Infected Patients With Chronic Hepatitis C

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2012; 61(5): 552-556 Nº de citas: 12 [doi:10.1097/QAI.0b013e31826ea109]

Martinez, E; D'Albuquerque, PM; Llibre, JM; Gutierrez, F; Podzamczer, D; Antela, A; Berenguer, J; Domingo, P; Moreno, X; Perez, I; Pich, J; Gatell, JM.

Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir

AIDS. 2012; 26(18): 2315-2326 Nº de citas: 117 [doi:10.1097/QAD.0b013e328359f29c]

Berenguer, J; Alejos, B; Hernando, V; Viciana, P; Salavert, M; Santos, I; Gomez-Sirvent, JL; Vidal, F; Portilla, J; Del Amo, J.

Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy

AIDS. 2012; 26(17): 2241-2246 Nº de citas: 37 [doi:10.1097/QAD.0b013e3283574e94]

Suarez-Lozano, I; Domingo, P; Lozano, F; Viciana, P; Lopez-Aldeguer, J; Terron, A; Munoz-Sanchez, J; Galindo, MJ; Cosin, J; Geijo, P; Ribera, E; Roca, B; Sanchez, T; Munoz-Sanz, A; de la Puente, B; Deig, E; Vergara, A; Vidal, F; Pedrol, E; Teira, R; Estrada, V; Castano, M; Puig, T; Garrido, M.

Budget impact analysis of antiretroviral therapy. A reflection based on the GESIDA guidelines

Gaceta Sanitaria. 2012; 26(6): 541-546 Nº de citas: 3 [doi:10.1016/j.gaceta.2012.01.015]

Resino, S; Sanchez-Conde, M; Berenguer, J.

Coinfection by human immunodeficiency virus and hepatitis C virus: noninvasive assessment and staging of fibrosis

CURRENT OPINION IN INFECTIOUS DISEASES. 2012; 25(5): 564-569 Nº de citas: 30 [doi:10.1097/QCO.0b013e32835635df]